A First in Human Study, Evaluating the Safety and Efficacy of ADAM™ 1.0

NCT05134428 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Contraline, Inc